121 related articles for article (PubMed ID: 15952303)
1. [Genetic analysis and individualized therapy for diffuse glioma].
Watanabe T; Yoshino A; Katayama Y
No Shinkei Geka; 2005 Jun; 33(6):537-53. PubMed ID: 15952303
[No Abstract] [Full Text] [Related]
2. Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
Schäfer N; Tichy J; Thanendrarajan S; Kim Y; Stuplich M; Mack F; Rieger J; Simon M; Scheffler B; Boström J; Steinbach JP; Herrlinger U; Glas M
Oncology; 2011; 80(5-6):330-2. PubMed ID: 21791942
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
4. [p16 tumor suppressor gene alteration in brain tumors].
Kumanishi T
No To Shinkei; 1998 Jun; 50(6):511-7. PubMed ID: 9656246
[No Abstract] [Full Text] [Related]
5. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
Jeremić B; Grujicić D; Matović M
Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
[TBL] [Abstract][Full Text] [Related]
6. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
[No Abstract] [Full Text] [Related]
7. Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapy.
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
Cancer Treat Rep; 1984 Feb; 68(2):431-3. PubMed ID: 6697333
[No Abstract] [Full Text] [Related]
8. [Molecular genetic analysis in the clinical neuro-oncology].
Ueki K
No To Shinkei; 2001 Jan; 53(1):41-9. PubMed ID: 11211729
[No Abstract] [Full Text] [Related]
9. [Chemotherapy for brain tumor].
Takahashi H; Tanaka R
Nihon Rinsho; 2005 Sep; 63 Suppl 9():452-5. PubMed ID: 16201563
[No Abstract] [Full Text] [Related]
10. [Evolution of chemotherapy for malignant brain tumors].
Takeshima H; Kuratsu J
No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
[No Abstract] [Full Text] [Related]
11. Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
Tonder M; Weller M; Eisele G; Roth P
Chemotherapy; 2014; 60(5-6):375-8. PubMed ID: 26496463
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin and etoposide for recurrent malignant glioma: one department's experience.
Stein ME; Tzuk-Shina Z; Ravkin A; Drumea K; Goldsher D
Am J Clin Oncol; 1998 Apr; 21(2):215-6. PubMed ID: 9537216
[No Abstract] [Full Text] [Related]
13. [Clinical significance of mustoforan in management of malignant glioma].
Kobiakov GL
Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
[No Abstract] [Full Text] [Related]
14. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
15. Management of pilomyxoid astrocytomas: our experience.
Tsugu H; Oshiro S; Yanai F; Komatsu F; Abe H; Fukushima T; Nomura Y; Matsumoto S; Nabeshima K; Takano K; Utsunomiya H
Anticancer Res; 2009 Mar; 29(3):919-26. PubMed ID: 19414328
[TBL] [Abstract][Full Text] [Related]
16. [Recent advances in chemotherapy for malignant gliomas].
Yoshino A; Katayama Y
No Shinkei Geka; 2008 Feb; 36(2):173-83. PubMed ID: 18265701
[No Abstract] [Full Text] [Related]
17. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of gene expression profiles in malignant brain tumors with respect to sensitivity to therapies].
Yamanaka R; Morii K; Takahashi H; Tanaka R; Nishio K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():49-54. PubMed ID: 16201499
[No Abstract] [Full Text] [Related]
20. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
